Statins in liver disease: a molehill, an iceberg, or neither?
about
Statins and its hepatic effects: Newer data, implications, and changing recommendationsHepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepStatins for primary cardiovascular prevention in the elderlyStrategies to rescue steatotic livers before transplantation in clinical and experimental studiesStatin associated hepatic adverse effects: a retrospective review from a regional hospital in sultanate of omanStatins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice.Safety of statins: an updateNonalcoholic fatty liver disease and aging: epidemiology to management.Statin use in patients with cirrhosis: a retrospective cohort study.Treating statin-intolerant patientsAn Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.Nonalcoholic fatty liver disease and cardiovascular risk.Management of statin intoleranceTreatment of non-alcoholic fatty liver disease with focus on emerging drugs.Expert opinion on current therapies for nonalcoholic fatty liver disease.Clinical perspective: statins and the liver--harmful or helpful?Potential for statins in the chemoprevention and management of hepatocellular carcinoma.Towards companion diagnostics for the management of statin therapy.Primary prevention of cardiovascular disease with statins in the elderly.Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.Pharmacogenomic and personalized approaches to tackle nonalcoholic fatty liver disease.Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea.Lovastatin interacts with natural products to influence cultured hepatocarcinoma cell (hep-g2) growth.ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.Nonalcoholic fatty liver disease: from lipid profile to treatment.ANMCO Position Paper: diagnostic-therapeutic pathway in patients with hypercholesterolaemia and statin intoleranceTherapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome.Bioenergetic study of murine hepatic tissue treated in vitro with atorvastatinRosuvastatin counteracts vessel arterialisation and sinusoid capillarisation, reduces tumour growth, and prolongs survival in murine hepatocellular carcinoma.Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation.Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial.Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial.Prescribing a statin to a cirrhotic patient to reduce hepatic decompensation and improve survival: impossible you say?
P2860
Q26767065-77EDCBE8-8896-405C-8620-60AAF962DBE8Q26771518-0C2D7F50-9438-4750-9535-336DA83401F7Q26783401-35B931C2-CFFC-4EF2-B8E1-4324E6536EC4Q27003912-4AEB2CD5-150E-49A6-AAD7-230575E19B41Q28654581-EDDC602D-B954-40E1-A4B4-F9EBAFD5DB33Q33765060-0531F290-A81F-4FA3-8885-3956F5B20CBCQ33944911-A8160767-D76B-4A35-A971-02098621985EQ33949312-9BC201B0-95F9-43C3-A319-54E6BC4036B7Q34366861-0DDF90DB-10F9-40C2-B711-2EC1A9115CAFQ34661975-39CA9575-FF7B-4B34-B61A-F28E01C316BAQ35110510-18695E8D-7F1A-442D-AF71-B8B9D902E6B2Q36328050-A559F70A-0ED8-41A4-A9BF-EFAA7CE5C189Q36393781-169B5BC9-F113-4907-97A8-D6EB2C68FC60Q37318761-44184754-B07E-4941-B522-4B1FCCB5E2DFQ37414000-9F410225-3EB7-40CA-8480-8374435ACD76Q37847181-08A98248-5C84-496D-BF97-3D824F0E4E54Q37884620-5B8FC1AD-5ECA-408A-8C04-2F5B9FB156FCQ38009719-4803E35D-CF23-489E-A2F4-9F2BEE3F0706Q38030991-7583365C-33BD-4856-A31F-EEC4675B7E2CQ38089842-3351CB75-41DC-472E-8613-21AA532FA0E1Q38208222-A66ABD9F-3143-4AEF-997A-6CAA4921629EQ38261236-33A9D965-8C60-4AED-A0AC-9C501DD33AEEQ38782562-33D84C09-0C94-4FC7-8FE1-E39FD8AD04BDQ38791719-A383C751-04DA-4F26-9762-C6950E118FD5Q38845334-12E785BF-8210-4B57-A710-2CBE6FF92C0DQ38890066-40030F25-9FE8-4548-966C-F5ACBCE984B0Q39656742-E07ABF32-B54F-4217-9596-757BB9CF5B54Q40104818-00A32B3C-7463-4B30-AC0E-5AFE9017EBC9Q40729988-D5D38CB2-4298-4FD3-92A9-EACFA575C12AQ41082961-7BC0104C-442F-484E-8DD7-2F42814457A5Q41093207-AA44E877-B800-420D-9574-300679B904D4Q42160233-9FD48ADE-6AF8-4E2B-B989-1D30B0E1EFC8Q42721917-496B0017-BE5E-490D-8132-9388228A1B73Q44206097-3FEA3E8F-696A-4B81-AF31-0EE3421BC693Q47868469-2BF41AD6-F1F0-4561-9FB6-0386212CC85BQ53272521-77ECFC64-848C-4AFE-8A70-AADC2A6E9312Q55058377-2C7745F3-AE48-4B72-AD07-774804A9DDFF
P2860
Statins in liver disease: a molehill, an iceberg, or neither?
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Statins in liver disease: a molehill, an iceberg, or neither?
@ast
Statins in liver disease: a molehill, an iceberg, or neither?
@en
type
label
Statins in liver disease: a molehill, an iceberg, or neither?
@ast
Statins in liver disease: a molehill, an iceberg, or neither?
@en
prefLabel
Statins in liver disease: a molehill, an iceberg, or neither?
@ast
Statins in liver disease: a molehill, an iceberg, or neither?
@en
P2093
P2860
P356
P1433
P1476
Statins in liver disease: a molehill, an iceberg, or neither?
@en
P2093
Curtis K Argo
Paola Loria
Stephen H Caldwell
P2860
P304
P356
10.1002/HEP.22402
P407
P577
2008-08-01T00:00:00Z